Source: Annual Congress 2006 - Epidemiology, clinical features, malignant pleural diseases, treatment
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. Hernando Sanz, E. Perez Rodriguez, F. Troncoso Acevedo, R. Gomez Garcia, M. Valle Falcones, S. Diaz Lobato, E. Manas, R. Light (Madrid, Spain; Nashville, United States Of America). Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy?. Eur Respir J 2006; 28: Suppl. 50, 4488

Member's Comments

No comment yet.

Related content which might interest you: Incidence and aetiology of eosinophilic pleural effusion Source: Eur Respir J 2009; 34: 1111-1117 Year: 2009 Is it important to determine pleural fluid amylase in patients with malignant pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007 Pleural fluid leptin level for the differential diagnosis of pleural effusion Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006 Pleural fluid, serum β-HCG levels and pleural fluid/serum β-HCG ratio for the discrimination of malignant and benign pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Diagnostic approach in a patient with pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131 Year: 2002 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Utility of pleural fluid glucose measurement in TB pleural effusions. Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Management of malignant pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 Pleural fluid procalcitonin levels in identifying pleural effusions due to infection Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections Year: 2009 Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110 Year: 2002 Combined use of pleural fluid adenosine deaminase and lymphocyte/neutrophil ratio for the diagnosis of tuberculous pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 33s Year: 2004 Measurement of pleural fluid lactate dehydrogenase and adenosine deaminase for distinguishing malignant pleural effusions and other exudative pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 246s Year: 2004 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003